CIRSE 2023

Join our sessions

Find out more about the scientific activities taking place at our hybrid symposia at CIRSE 2023

Sunday, 10/09
Monday, 11/09

Sunday, 10th September

9:00 - 10:15 Sunday, 10th September Terumo Learning Centre

Terumo Learning Edge

You can only treat what you can reach: Strategies / algorithms for lower limb revascularization

Learn about the strategies for complex lesion crossing in Fempop and below the knee.
Experimenting with lesion crossing with the different tools and techniques.

Speaker: Dr. L. Patrone

13:00 - 14:00 Monday, 11th September Terumo Learning Centre

Terumo Learning Edge

Guide for guidewires

Learn the tools to perform a good access for peripheral interventions

Speaker: Dr. L. Maene

14:30 - 15:30 Monday, 11th September Terumo Learning Centre

Terumo Learning Edge

Best practice in R2V - Radial to Visceral

Learn about best practice and tips and tricks in R2V: UFE, PAE, Liver directed therapies and 12 months outcomes of prospective, multi-center registry study
Hands-on using devices for R2V

Speakers: Dr. M. Guimaraes and Prof. R. Iezzi

Monday, 11th September

9:00 - 10:15 Sunday, 10th September Terumo Learning Centre

Terumo Learning Edge

You can only treat what you can reach: Strategies / algorithms for lower limb revascularization

Learn about the strategies for complex lesion crossing in Fempop and below the knee.
Experimenting with lesion crossing with the different tools and techniques.

Speaker: Dr. L. Patrone

13:00 - 14:00 Monday, 11th September Terumo Learning Centre

Terumo Learning Edge

Guide for guidewires

Learn the tools to perform a good access for peripheral interventions

Speaker: Dr. L. Maene

14:30 - 15:30 Monday, 11th September Terumo Learning Centre

Terumo Learning Edge

Best practice in R2V - Radial to Visceral

Learn about best practice and tips and tricks in R2V: UFE, PAE, Liver directed therapies and 12 months outcomes of prospective, multi-center registry study
Hands-on using devices for R2V

Speakers: Dr. M. Guimaraes and Prof. R. Iezzi

Other activities

Auditorium 10

FS 115 – Optimising radioembolisation for liver tumours

FS115.4 – Holmium TARE
Saturday 9th of September
09:15 – 09:30

Learning Objectives:
To explain the technique and the best setting to perform it
To review current studies on complications, clinical outcomes and overall survival
To discuss new approaches (intraprocedural MRI-based dosimetry)

Speaker: Dr. M. Smits

Auditorium 2

SP 131 – FIRST@CIRSE: First data release on arterial trials and studies

1-year outcomes of a dual-layer micromesh stent in endovascular carotid stenosis treatment: evidence from a large multicentre European ROADSAVER study.

Saturday 9th of September
11:21 - 11:32

Speaker: Dr. R. Langhoff

Auditorium 10

FS 135 – Thyroid thermal ablation

FS135.2 – Technique for a safe and effective thyroid thermal ablation.
Saturday 9th of September
11:45 - 12:00

Learning Objectives:
To describe the different ablation techniques for thyroid lesions and recurrences
To analyse the level of evidence of different techniques
To identify tips and tricks for avoiding complications

Speaker: Dr. T. Dionisio

News on stage

MPI 141 – Clinical trials in arterial disease and mechanical thrombectomy: Meet the PI

PRIZER: Post-market, Single aRm study, to confIrm the performance of the RenZan™ Peripheral Stent System in treating subjects with SupErficial Femoral and/or Popliteal aRtery disease.

Saturday 9th of September
13:00 - 13:15

Speaker: Dr. K. Deloose

Room 18

SP 177 – Carotid artery stenting in acute and elective settings and miscellaneous

30-day safety outcomes of patients treated with a dual-layer micromesh carotid artery stent via radial or femoral access route: evidence from a large multicentre European study (ROADSAVER).

Saturday 9th of September
17:30 - 17:38

Speaker: Dr. A. Gjoreski

Room 18

SP 177 – Carotid artery stenting in acute and elective settings and miscellaneous

30-day safety outcomes of diabetic and nondiabetic patients featuring carotid artery stenosis treated with a dual-layer micromesh stent: evidence from a large multicentre European study (ROADSAVER).

Saturday 9th of September
17:38 - 17:46

Speaker: Prof. Dr. med. S. Müller-Hülsbeck

Auditorium 1

FS 223 – HCC: which patients, which tumours

FS223.1 – Ablation: enough evidence to treat nodules > 3cm.

Sunday 10th of September
10:00 - 10:15

Learning Objectives:
To describe the current guidelines in recommending ablation for HCC
To evaluate the outcomes of ablation in HCC
To propose an optimised therapeutic algorithm for very early and early HCC

Speaker: Prof. L. Crocetti

Auditorium 15

FS 314 – Real-world evidence in interventional oncology: from palliative to curative applications

FS314.1 - Effectiveness outcomes of chemoembolization with irinotecan-eluting beads used in CRLM in 98 patients treated in curative, first line or intensification settings and 46 patients treated in a palliative setting (CIREL).

Monday 11th of September
08:30 - 08:45

Learning Objectives:
To learn about the effectiveness outcomes of patients treated in a non-palliative and palliative setting included in CIREL
To contextualise the findings of CIREL with the current evidence-base of TACE in metastatic colorectal cancer
To learn about the predictive factors for decreased survival of patients treated with irinotecan-eluting beads

Speaker: Prof. A. Gjoreski

Auditorium 12

SP 467 – FIRST@CIRSE: First data release on various IR trials and studies

SP 467 – FIRST@CIRSE: First data release on various IR trials and studies
467.4 / 166Holmium-SIRT after PRRT (HEPAR PLuS) versus PRRT alone in patients with metastatic neuroendocrine tumors: a propensity score matched analysis.

Tuesday 12th of September
16:45 - 16:55

Speaker: Dr. A. Braat

Room 20

SP 476 – PAD: the bigger picture

FIRST@CIRSE Clinical Trial
ANGIO-SEAL CLOSE: Prospective Multicentre Observational Study with Vascular Closure Device (VCD) Angio-Seal™ VIP Following Arterial Endovascular Procedures.

Tuesday 12th of September
17:40 - 17:50

Speaker: Prof. M. Sapoval

Do you need more info about this product?

Our sales representatives are here for you.

Send us a message

First name *

Last name *

Function

Company *

Country *

E-mail address *

Question *

I have read and accept Terumo Privacy And Cookies Policy and the Terms Of Use*

I wish to receive information and marketing updates from Terumo.

* mandatory fields

Thank you for contacting us!

We typically respond within 2 business days and will come back to you as soon as possible.

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public

For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.

This webpage can include promotional content regarding one or several products... of Terumo Europe, or some procedures concerning the use or implantation of such products.This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public.

For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.

This site uses cookies to improve your user experience.

This site uses cookies. Functional cookies are necessary for the use of this website and cannot be refused. Other cookies are only placed if you choose to do so. For further information please read our cookies notice.

This site uses cookies. Functional cookies are necessary for the use of this ... website and cannot be refused. Other cookies are only placed if you choose to do so. For further information, please read our cookies policy.

CIRSE 2023

Join our sessions

Would you like to set up a meeting or get more information?

Sunday, 10th September

9:00 - 10:15 Sunday, 10th September Terumo Learning Centre

You can only treat what you can reach: Strategies / algorithms for lower limb revascularization

13:00 - 14:00 Monday, 11th September Terumo Learning Centre

Guide for guidewires

14:30 - 15:30 Monday, 11th September Terumo Learning Centre

Best practice in R2V - Radial to Visceral

Monday, 11th September

9:00 - 10:15 Sunday, 10th September Terumo Learning Centre

You can only treat what you can reach: Strategies / algorithms for lower limb revascularization

13:00 - 14:00 Monday, 11th September Terumo Learning Centre

Guide for guidewires

14:30 - 15:30 Monday, 11th September Terumo Learning Centre

Best practice in R2V - Radial to Visceral

Other activities

Auditorium 10

FS 115 – Optimising radioembolisation for liver tumours

Auditorium 2

SP 131 – FIRST@CIRSE: First data release on arterial trials and studies

1-year outcomes of a dual-layer micromesh stent in endovascular carotid stenosis treatment: evidence from a large multicentre European ROADSAVER study.​Saturday 9th of September11:21 - 11:32Speaker: Dr. R. Langhoff

Auditorium 10

FS 135 – Thyroid thermal ablation

News on stage

MPI 141 – Clinical trials in arterial disease and mechanical thrombectomy: Meet the PI

PRIZER: Post-market, Single aRm study, to confIrm the performance of the RenZan™ Peripheral Stent System in treating subjects with SupErficial Femoral and/or Popliteal aRtery disease.Saturday 9th of September13:00 - 13:15Speaker: Dr. K. Deloose

Room 18

SP 177 – Carotid artery stenting in acute and elective settings and miscellaneous

30-day safety outcomes of patients treated with a dual-layer micromesh carotid artery stent via radial or femoral access route: evidence from a large multicentre European study (ROADSAVER).Saturday 9th of September17:30 - 17:38Speaker: Dr. A. Gjoreski

Room 18

SP 177 – Carotid artery stenting in acute and elective settings and miscellaneous

30-day safety outcomes of diabetic and nondiabetic patients featuring carotid artery stenosis treated with a dual-layer micromesh stent: evidence from a large multicentre European study (ROADSAVER).Saturday 9th of September17:38 - 17:46Speaker: Prof. Dr. med. S. Müller-Hülsbeck

Auditorium 1

FS 223 – HCC: which patients, which tumours

Auditorium 15

FS 314 – Real-world evidence in interventional oncology: from palliative to curative applications

Auditorium 12

SP 467 – FIRST@CIRSE: First data release on various IR trials and studies

SP 467 – FIRST@CIRSE: First data release on various IR trials and studies467.4 / 166Holmium-SIRT after PRRT (HEPAR PLuS) versus PRRT alone in patients with metastatic neuroendocrine tumors: a propensity score matched analysis.Tuesday 12th of September16:45 - 16:55 Speaker: Dr. A. Braat

Room 20

SP 476 – PAD: the bigger picture

FIRST@CIRSE Clinical TrialANGIO-SEAL CLOSE: Prospective Multicentre Observational Study with Vascular Closure Device (VCD) Angio-Seal™ VIP Following Arterial Endovascular Procedures.Tuesday 12th of September17:40 - 17:50Speaker: Prof. M. Sapoval

Some of our highlighted products at the conference

Do you need more info about this product?

Send us a message

Are you a healthcare professional?

This site uses cookies to improve your user experience.

1-year outcomes of a dual-layer micromesh stent in endovascular carotid stenosis treatment: evidence from a large multicentre European ROADSAVER study.

Saturday 9th of September
11:21 - 11:32

Speaker: Dr. R. Langhoff

PRIZER: Post-market, Single aRm study, to confIrm the performance of the RenZan™ Peripheral Stent System in treating subjects with SupErficial Femoral and/or Popliteal aRtery disease.

Saturday 9th of September
13:00 - 13:15

Speaker: Dr. K. Deloose

30-day safety outcomes of patients treated with a dual-layer micromesh carotid artery stent via radial or femoral access route: evidence from a large multicentre European study (ROADSAVER).

Saturday 9th of September
17:30 - 17:38

Speaker: Dr. A. Gjoreski

30-day safety outcomes of diabetic and nondiabetic patients featuring carotid artery stenosis treated with a dual-layer micromesh stent: evidence from a large multicentre European study (ROADSAVER).

Saturday 9th of September
17:38 - 17:46

Speaker: Prof. Dr. med. S. Müller-Hülsbeck

SP 467 – FIRST@CIRSE: First data release on various IR trials and studies
467.4 / 166Holmium-SIRT after PRRT (HEPAR PLuS) versus PRRT alone in patients with metastatic neuroendocrine tumors: a propensity score matched analysis.

Tuesday 12th of September
16:45 - 16:55

Speaker: Dr. A. Braat

FIRST@CIRSE Clinical Trial
ANGIO-SEAL CLOSE: Prospective Multicentre Observational Study with Vascular Closure Device (VCD) Angio-Seal™ VIP Following Arterial Endovascular Procedures.

Tuesday 12th of September
17:40 - 17:50

Speaker: Prof. M. Sapoval